Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science and Technology, Hisar, Haryana, India.
BMC Complement Altern Med. 2012 Sep 3;12:145. doi: 10.1186/1472-6882-12-145.
Obesity is recognized as a social problem, associated with serious health risks and increased mortality. Numerous trials have been conducted to find and develop new anti-obesity drugs through herbal sources to minimize side effects associated with the present anti-obesity drugs. The present study was designed to evaluate the quality control parameters, quantitative phytochemical analysis (total phenolic, total flavonoids and total saponin content), and the anti-obesity effect of lyophilized juice (LJ) of Stellaria media (Linn.) Vill. by employing in vitro and in vivo models.
In vitro studies were performed to evaluate the inhibitory activity of LJ on pancreatic amylase and lipase. The in vivo pancreatic lipase activity was evaluated by measurement of plasma triacylglycerol levels after oral administration of lipid emulsion to swiss albino mice. Furthermore, the anti-obesity effect of LJ was assessed at two doses, 400 mg/kg and 900 mg/kg body weight in mice fed a high-fat-diet with or without LJ for 6 weeks.
The LJ inhibited pancreatic amylase and lipase activity in vitro and elevated plasma triacylglycerol level in mice. LJ suppressed the increase in body weight, retroperitoneal adipose tissue, liver weights and serum parameters viz., total cholesterol, total triglyceride, LDL-cholesterol level at the dose of 900 mg/kg body weight of the mice fed with high fat diet. The total phenolic, flavonoid and saponin contents were found to be 0.26 mg/g, 1.4 mg/g and 1.19 μg/g respectively of LJ.
The anti-obesity effects of LJ in high-fat-diet fed mice may be partly mediated through delaying the intestinal absorption of dietary fat and carbohydrate by inhibiting digestive enzymes.
肥胖被认为是一个社会问题,与严重的健康风险和死亡率增加有关。已经进行了许多试验,以寻找和开发新的草药来源的抗肥胖药物,以最大限度地减少与现有抗肥胖药物相关的副作用。本研究旨在通过体外和体内模型评估旋覆花冻干汁(LJ)的质量控制参数、定量植物化学分析(总酚、总黄酮和总皂苷含量)和抗肥胖作用。
进行体外研究以评估 LJ 对胰淀粉酶和脂肪酶的抑制活性。通过测量口服脂肪乳剂后血浆三酰甘油水平来评估体内胰脂肪酶活性。此外,在高脂肪饮食中给予或不给予 LJ 的情况下,以 400 mg/kg 和 900 mg/kg 体重两种剂量评估 LJ 的抗肥胖作用,持续 6 周。
LJ 在体外抑制胰淀粉酶和脂肪酶活性,并在小鼠中升高血浆三酰甘油水平。LJ 抑制了高脂肪饮食喂养的小鼠体重、腹膜后脂肪组织、肝脏重量和血清参数(即总胆固醇、总甘油三酯、LDL-胆固醇水平)的增加,剂量为 900 mg/kg 体重。LJ 的总酚、黄酮和皂苷含量分别为 0.26 mg/g、1.4 mg/g 和 1.19 μg/g。
LJ 在高脂肪饮食喂养的小鼠中的抗肥胖作用可能部分是通过抑制消化酶来延迟膳食脂肪和碳水化合物的肠道吸收来介导的。